ILUTS22
#SoracteLite is the application of Echolaser in #urology field. With a #transperineal and #microinvasive (21G needle) approach the procedure is carried out without any complication and with the preservation of the ejaculation and urination functionality. ...
EAU – European Association of Urology
Elesta will attend at #EAU22 congress in Amsterdam. Come to meet us at BOOTH B61! Discover #EchoLaser a micro invasive technique for #BPH and #PCa. #SoracteLite #prostate #TPLA
50 anni di urologia e non sentirli
Prato, Toscana La tecnica mini-invasiva di EchoLaser è stata presentata all'evento di urologia Toscano "50 anni di urologia e non sentirli", come tecnica innovativa, efficace e sicura.
Elesta EchoLaser results of the first USA clinical trial presented at AUA 2022 in New Orleans.
Click the link below to read about the new results presented in AUA22 congress! https://markets.businessinsider.com/news/stocks/ultrasound-and-elesta-announces-first-clinical-data-for-echolaser-for-tpla-presented-at-aua-2022-1031488936
SoracteLite & Aramed
Aramed porta nel mondo la nostra tecnologia SoracteLite